vitiligo
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who are clearly diagnosed as vitiligo, and those who have been diagnosed as blood stasis syndrome by Chinese medicine; 2. Patients aged 18 to 60 years; 3. Mainly confined and sporadic; 4. In order to accurately compare the test results, the hypopigmented area of all patients in this test is <= 10% of the total body surface area; 5. No systemic or topical glucocorticoid or immunosuppressant treatment or withdrawal of the drug for more than 3 months within 3 months; 6. Patients with leukoplakia that have not expanded within 6 months and are in a stable phase; 7. Patients who agree to take pictures of the skin lesions and can complete the treatment and follow-up on time.
Exclusion criteria
Exclusion criteria: 1. Pregnant and lactating women; 2. System or topical vitiligo drug treatment within 3 months; 3. Patients who are allergic to tacrolimus ointment and compound Honghuabuji granules. 4. Patients with severe heart, liver, kidney and other system diseases; 5. Patients who withdraw halfway and have incomplete information.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| White spot area; | — |
Secondary
| Measure | Time frame |
|---|---|
| Vitiligo impact scale-22;TCM symptoms scale; | — |
Countries
China
Contacts
Shanghai Dermatology Hospital